Хайлтын үр дүнгүүд - Ricard Mesı́a

Үр дүнг сайжруулах
  1. 1
    Cetuximab-Containing Combinations in Locally Advanced and Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

    Cetuximab-Containing Combinations in Locally Advanced and Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma -н Miren Taberna, Marc Oliva, Ricard Mesı́a

    Хэвлэсэн 2019
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  2. 2
    Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised grading system and consensus management guidelines

    Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised gradi... -н J. Bernier, Elvio Russi, Bernhard Homey, Marco Merlano, Ricard Mesı́a, Fréderic Peyrade, Wilfried Budach

    Хэвлэсэн 2011
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  3. 3
    Human papillomavirus-related oropharyngeal cancer

    Human papillomavirus-related oropharyngeal cancer -н Miren Taberna, M. Mena, Miguel Ángel Pavón, Laia Alemany, Maura L. Gillison, Ricard Mesı́a

    Хэвлэсэн 2017
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  4. 4
    The Evolving Role of Taxanes in Combination With Cetuximab for the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: Evidence, Advantages, and Future Directions

    The Evolving Role of Taxanes in Combination With Cetuximab for the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: Evidence, Advantages, and... -н J. Guigay, Makoto Tahara, Lisa Licitra, Ulrich Keilholz, Signe Friesland, Pauline Witzler, Ricard Mesı́a

    Хэвлэсэн 2019
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  5. 5
    Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma

    Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma -н Marc Oliva, Anna Spreafico, Miren Taberna, Laia Alemany, Bryan Coburn, Ricard Mesı́a, Lillian L. Siu

    Хэвлэсэн 2018
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  6. 6
    Opioid-Induced Constipation in Oncological Patients: New Strategies of Management

    Opioid-Induced Constipation in Oncological Patients: New Strategies of Management -н Ricard Mesı́a, Juan Antonio Virizuela Echaburu, J.M. González Gómez, Tamara Saurí, Gloria Serrano, Eduardo Pujol

    Хэвлэсэн 2019
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  7. 7
    Phase I/II trial of cilengitide with cetuximab, cisplatin and 5-fluorouracil in recurrent and/or metastatic squamous cell cancer of the head and neck: findings of the phase I part

    Phase I/II trial of cilengitide with cetuximab, cisplatin and 5-fluorouracil in recurrent and/or metastatic squamous cell cancer of the head and neck: findings of the phase I part -н Jan B. Vermorken, J. Guigay, Ricard Mesı́a, José Trigo, Ulrich Keilholz, A. Kerber, Ullrich Bethe, Martin Picard, T. Brümmendorf

    Хэвлэсэн 2011
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  8. 8
    Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial

    Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: re... -н Jan B. Vermorken, Amanda Psyrri, Ricard Mesı́a, Fréderic Peyrade, Frank Beier, Barbara de Blas, İ. Çelik, Lisa Licitra

    Хэвлэсэн 2014
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  9. 9
    Evaluation of the benefit and use of multidisciplinary teams in the treatment of head and neck cancer

    Evaluation of the benefit and use of multidisciplinary teams in the treatment of head and neck cancer -н Lisa Licitra, Ulrich Keilholz, Makoto Tahara, Jin‐Ching Lin, Pauline Chomette, Philippe Céruse, Kevin J. Harrington, Ricard Mesı́a

    Хэвлэсэн 2016
    Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  10. 10
    Update on Management Recommendations for Advanced Cutaneous Squamous Cell Carcinoma

    Update on Management Recommendations for Advanced Cutaneous Squamous Cell Carcinoma -н Jesús García‐Foncillas, A. Tejera‐Vaquerizo, Onofre Sanmartín, Federico Rojo, Javier Mestre, Salvador Martín, Ignacio Azinovic, Ricard Mesı́a

    Хэвлэсэн 2022
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  11. 11
    The Multidisciplinary Team (MDT) Approach and Quality of Care

    The Multidisciplinary Team (MDT) Approach and Quality of Care -н Miren Taberna, Francisco Gil Moncayo, Enric Jané Salas, Maite Antonio, Lorena Arribas, Esther Vilajosana, Elisabet Peralvez Torres, Ricard Mesı́a

    Хэвлэсэн 2020
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  12. 12
    SEOM clinical guidelines for the treatment of head and neck cancer (2020)

    SEOM clinical guidelines for the treatment of head and neck cancer (2020) -н Ricard Mesı́a, L. Iglesias, J. Lambea, Javier Martínez‐Trufero, Ainara Soria, Miren Taberna, José Trigo, M. Chaves, Almudena García‐Castaño, Juan Jesús Cruz

    Хэвлэсэн 2021
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  13. 13
    Molecular Alterations and Buparlisib Efficacy in Patients with Squamous Cell Carcinoma of the Head and Neck: Biomarker Analysis from BERIL-1

    Molecular Alterations and Buparlisib Efficacy in Patients with Squamous Cell Carcinoma of the Head and Neck: Biomarker Analysis from BERIL-1 -н Denis Soulières, Lisa Licitra, Ricard Mesı́a, Éva Remenár, Shau-Hsuan Li, А. А. Карпенко, Marie Chol, Ying A. Wang, Nadia Solovieff, Laurence Bourdeau, Dalila Sellami, Sandrine Faivre

    Хэвлэсэн 2018
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  14. 14
    Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study

    Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metasta... -н Lisa Licitra, Ricard Mesı́a, Fernando Rivera, Éva Remenár, Ricardo Hitt, J. Erfán, Sylvie Rottey, Andrzej Kawecki, D. Zabolotnyy, Marco Benasso, Stephan Störkel, Stefanie Senger, Christopher Stroh, JB Vermorken

    Хэвлэсэн 2010
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  15. 15
    Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck

    Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous... -н J. Bernier, James A. Bonner, Jan B. Vermorken, R.J. Bensadoun, Reinhard Dummer, J. Giralt, Gabriela Kornek, A. Hartley, Ricard Mesı́a, Caroline Robert, Siegfried Segaert, K. Kian Ang

    Хэвлэсэн 2007
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  16. 16
    Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323)

    Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locor... -н Carla M.L. van Herpen, Murielle Mauer, Ricard Mesı́a, M. Degardin, S. Jelić, Corneel Coens, Jan Betka, J. Bernier, Éva Remenár, J.S.W. Stewart, JC Preiß, D. Van den Weyngaert, Andrew Bottomley, Jan B. Vermorken

    Хэвлэсэн 2010
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  17. 17
    Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck

    Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck -н Ricard Mesı́a, Fernando Rivera, Andrzej Kawecki, Sylvie Rottey, Ricardo Hitt, H. Kienzer, Didier Cupissol, D. De Raucourt, Marco Benasso, P. Koralewski, J.P. Delord, Carsten Bokemeyer, Desmond Curran, Andrew J. Gross, J. B. Vermorken

    Хэвлэсэн 2010
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  18. 18
    Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)

    Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/I... -н Jan B. Vermorken, Fréderic Peyrade, John C. Krauss, Ricard Mesı́a, Éva Remenár, Thomas Gauler, Ulrich Keilholz, Jean‐Pierre Delord, Philippe Schafhausen, J. Erfán, Tim H. Brümmendorf, L. Iglesias, Ullrich Bethe, Christine Hicking, Paul M. Clément

    Хэвлэсэн 2014
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  19. 19
    A phase Ib/II study (SCORES) of durvalumab (D) plus danvatirsen (DAN; AZD9150) or AZD5069 (CX2i) in advanced solid malignancies and recurrent/metastatic head and neck squamous cell carcinoma (RM-HNSCC): Updated results

    A phase Ib/II study (SCORES) of durvalumab (D) plus danvatirsen (DAN; AZD9150) or AZD5069 (CX2i) in advanced solid malignancies and recurrent/metastatic head and neck squamous cell... -н Ezra E.W. Cohen, Kevin J. Harrington, David S. Hong, Ricard Mesı́a, Irene Braña, Pedro Pérez Segura, Trisha M. Wise‐Draper, Martin Scott, Patrick D. Mitchell, Ganesh Mugundu, Patricia McCoon, Carl Cook, Minal Mehta, Ulrich Keilholz

    Хэвлэсэн 2018
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  20. 20
    Ibero-American Expert Consensus on Squamous Cell Carcinoma of the Head and Neck Treatment in Patients Unable to Receive Cisplatin: Recommendations for Clinical Practice

    Ibero-American Expert Consensus on Squamous Cell Carcinoma of the Head and Neck Treatment in Patients Unable to Receive Cisplatin: Recommendations for Clinical Practice -н Agustín Falco, Thiago Bueno de Oliveira, Jon Cacicedo, Aylen Vanessa Ospina, Miguel Ángel Ticona, Héctor Galindo, M.D. Pereira, José Luis Aguilar-Ponce, Antonio Rueda‐Domínguez, Tannia Soria, Miren Taberna, L. Iglesias, Taysser Sowley, Ricard Mesı́a

    Хэвлэсэн 2021
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:

Хайх хэрэгслүүд: